nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—FKBP1A—Cyclosporine—rheumatoid arthritis	0.496	0.755	CbGbCtD
Pimecrolimus—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0332	0.0505	CbGbCtD
Pimecrolimus—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0245	0.0373	CbGbCtD
Pimecrolimus—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0186	0.0282	CbGbCtD
Pimecrolimus—CYP3A4—Betamethasone—rheumatoid arthritis	0.0159	0.0242	CbGbCtD
Pimecrolimus—CYP3A4—Prednisolone—rheumatoid arthritis	0.0157	0.0239	CbGbCtD
Pimecrolimus—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.0149	0.0227	CbGbCtD
Pimecrolimus—CYP3A4—Prednisone—rheumatoid arthritis	0.0148	0.0226	CbGbCtD
Pimecrolimus—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0141	0.0214	CbGbCtD
Pimecrolimus—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00927	0.0141	CbGbCtD
Pimecrolimus—Conjunctivitis—Betamethasone—rheumatoid arthritis	0.00023	0.00126	CcSEcCtD
Pimecrolimus—Conjunctivitis—Dexamethasone—rheumatoid arthritis	0.00023	0.00126	CcSEcCtD
Pimecrolimus—Dyspnoea—Leflunomide—rheumatoid arthritis	0.000229	0.00126	CcSEcCtD
Pimecrolimus—Immune system disorder—Hydrocortisone—rheumatoid arthritis	0.000224	0.00123	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Azathioprine—rheumatoid arthritis	0.000223	0.00122	CcSEcCtD
Pimecrolimus—Angioedema—Cyclosporine—rheumatoid arthritis	0.000222	0.00122	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Leflunomide—rheumatoid arthritis	0.000222	0.00122	CcSEcCtD
Pimecrolimus—Erythema—Prednisolone—rheumatoid arthritis	0.000221	0.00121	CcSEcCtD
Pimecrolimus—Pain—Leflunomide—rheumatoid arthritis	0.00022	0.00121	CcSEcCtD
Pimecrolimus—Constipation—Leflunomide—rheumatoid arthritis	0.00022	0.00121	CcSEcCtD
Pimecrolimus—Eye disorder—Methylprednisolone—rheumatoid arthritis	0.000218	0.0012	CcSEcCtD
Pimecrolimus—Malnutrition—Hydrocortisone—rheumatoid arthritis	0.000216	0.00119	CcSEcCtD
Pimecrolimus—Erythema—Hydrocortisone—rheumatoid arthritis	0.000216	0.00119	CcSEcCtD
Pimecrolimus—Body temperature increased—Azathioprine—rheumatoid arthritis	0.000215	0.00118	CcSEcCtD
Pimecrolimus—Abdominal pain—Azathioprine—rheumatoid arthritis	0.000215	0.00118	CcSEcCtD
Pimecrolimus—Cough—Cyclosporine—rheumatoid arthritis	0.000212	0.00116	CcSEcCtD
Pimecrolimus—Immune system disorder—Methylprednisolone—rheumatoid arthritis	0.000211	0.00116	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Leflunomide—rheumatoid arthritis	0.00021	0.00115	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Methylprednisolone—rheumatoid arthritis	0.00021	0.00115	CcSEcCtD
Pimecrolimus—Arthralgia—Cyclosporine—rheumatoid arthritis	0.000207	0.00114	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—rheumatoid arthritis	0.000205	0.00113	CcSEcCtD
Pimecrolimus—Urticaria—Leflunomide—rheumatoid arthritis	0.000204	0.00112	CcSEcCtD
Pimecrolimus—Erythema—Triamcinolone—rheumatoid arthritis	0.000203	0.00112	CcSEcCtD
Pimecrolimus—Abdominal pain—Leflunomide—rheumatoid arthritis	0.000203	0.00111	CcSEcCtD
Pimecrolimus—Body temperature increased—Leflunomide—rheumatoid arthritis	0.000203	0.00111	CcSEcCtD
Pimecrolimus—Erythema—Methylprednisolone—rheumatoid arthritis	0.000203	0.00111	CcSEcCtD
Pimecrolimus—Malnutrition—Methylprednisolone—rheumatoid arthritis	0.000203	0.00111	CcSEcCtD
Pimecrolimus—Angioedema—Prednisolone—rheumatoid arthritis	0.000202	0.00111	CcSEcCtD
Pimecrolimus—Breast disorder—Methotrexate—rheumatoid arthritis	0.000202	0.00111	CcSEcCtD
Pimecrolimus—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.000201	0.0011	CcSEcCtD
Pimecrolimus—Oedema—Cyclosporine—rheumatoid arthritis	0.000198	0.00109	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Cyclosporine—rheumatoid arthritis	0.000198	0.00109	CcSEcCtD
Pimecrolimus—Eye disorder—Dexamethasone—rheumatoid arthritis	0.000198	0.00109	CcSEcCtD
Pimecrolimus—Eye disorder—Betamethasone—rheumatoid arthritis	0.000198	0.00109	CcSEcCtD
Pimecrolimus—Angioedema—Hydrocortisone—rheumatoid arthritis	0.000197	0.00108	CcSEcCtD
Pimecrolimus—Infection—Cyclosporine—rheumatoid arthritis	0.000197	0.00108	CcSEcCtD
Pimecrolimus—Back pain—Triamcinolone—rheumatoid arthritis	0.000197	0.00108	CcSEcCtD
Pimecrolimus—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.000195	0.00107	CcSEcCtD
Pimecrolimus—Asthma—Methotrexate—rheumatoid arthritis	0.000193	0.00106	CcSEcCtD
Pimecrolimus—Skin disorder—Cyclosporine—rheumatoid arthritis	0.000193	0.00106	CcSEcCtD
Pimecrolimus—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.000189	0.00104	CcSEcCtD
Pimecrolimus—Diarrhoea—Azathioprine—rheumatoid arthritis	0.000186	0.00102	CcSEcCtD
Pimecrolimus—Angioedema—Triamcinolone—rheumatoid arthritis	0.000186	0.00102	CcSEcCtD
Pimecrolimus—Angioedema—Methylprednisolone—rheumatoid arthritis	0.000185	0.00102	CcSEcCtD
Pimecrolimus—Erythema—Betamethasone—rheumatoid arthritis	0.000185	0.00101	CcSEcCtD
Pimecrolimus—Erythema—Dexamethasone—rheumatoid arthritis	0.000185	0.00101	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.000183	0.001	CcSEcCtD
Pimecrolimus—Pruritus—Leflunomide—rheumatoid arthritis	0.000182	0.000998	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Cyclosporine—rheumatoid arthritis	0.000181	0.000992	CcSEcCtD
Pimecrolimus—Oedema—Prednisolone—rheumatoid arthritis	0.00018	0.00099	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Prednisolone—rheumatoid arthritis	0.00018	0.00099	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Methotrexate—rheumatoid arthritis	0.000179	0.000983	CcSEcCtD
Pimecrolimus—Paraesthesia—Cyclosporine—rheumatoid arthritis	0.000178	0.000977	CcSEcCtD
Pimecrolimus—Cough—Triamcinolone—rheumatoid arthritis	0.000177	0.000974	CcSEcCtD
Pimecrolimus—Dyspnoea—Cyclosporine—rheumatoid arthritis	0.000177	0.00097	CcSEcCtD
Pimecrolimus—Oedema—Hydrocortisone—rheumatoid arthritis	0.000176	0.000967	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Hydrocortisone—rheumatoid arthritis	0.000176	0.000967	CcSEcCtD
Pimecrolimus—Photosensitivity reaction—Methotrexate—rheumatoid arthritis	0.000176	0.000965	CcSEcCtD
Pimecrolimus—Diarrhoea—Leflunomide—rheumatoid arthritis	0.000176	0.000965	CcSEcCtD
Pimecrolimus—Infection—Hydrocortisone—rheumatoid arthritis	0.000175	0.000961	CcSEcCtD
Pimecrolimus—Vomiting—Azathioprine—rheumatoid arthritis	0.000173	0.000949	CcSEcCtD
Pimecrolimus—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000173	0.000949	CcSEcCtD
Pimecrolimus—Pneumonia—Methotrexate—rheumatoid arthritis	0.000173	0.000949	CcSEcCtD
Pimecrolimus—Arthralgia—Methylprednisolone—rheumatoid arthritis	0.000173	0.000948	CcSEcCtD
Pimecrolimus—Eye disorder—Prednisone—rheumatoid arthritis	0.000173	0.000947	CcSEcCtD
Pimecrolimus—Infestation—Methotrexate—rheumatoid arthritis	0.000172	0.000943	CcSEcCtD
Pimecrolimus—Infestation NOS—Methotrexate—rheumatoid arthritis	0.000172	0.000943	CcSEcCtD
Pimecrolimus—Rash—Azathioprine—rheumatoid arthritis	0.000172	0.000942	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.000172	0.000941	CcSEcCtD
Pimecrolimus—Dermatitis—Azathioprine—rheumatoid arthritis	0.000171	0.000941	CcSEcCtD
Pimecrolimus—Flushing—Prednisone—rheumatoid arthritis	0.000171	0.00094	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.000171	0.00094	CcSEcCtD
Pimecrolimus—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.000171	0.00094	CcSEcCtD
Pimecrolimus—Headache—Azathioprine—rheumatoid arthritis	0.00017	0.000936	CcSEcCtD
Pimecrolimus—Constipation—Cyclosporine—rheumatoid arthritis	0.00017	0.000931	CcSEcCtD
Pimecrolimus—Pain—Cyclosporine—rheumatoid arthritis	0.00017	0.000931	CcSEcCtD
Pimecrolimus—Angioedema—Betamethasone—rheumatoid arthritis	0.000169	0.000925	CcSEcCtD
Pimecrolimus—Angioedema—Dexamethasone—rheumatoid arthritis	0.000169	0.000925	CcSEcCtD
Pimecrolimus—Conjunctivitis—Methotrexate—rheumatoid arthritis	0.000167	0.000917	CcSEcCtD
Pimecrolimus—Immune system disorder—Prednisone—rheumatoid arthritis	0.000167	0.000915	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Triamcinolone—rheumatoid arthritis	0.000166	0.000911	CcSEcCtD
Pimecrolimus—Oedema—Triamcinolone—rheumatoid arthritis	0.000166	0.000911	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Methylprednisolone—rheumatoid arthritis	0.000166	0.000909	CcSEcCtD
Pimecrolimus—Infection—Triamcinolone—rheumatoid arthritis	0.000165	0.000905	CcSEcCtD
Pimecrolimus—Infection—Methylprednisolone—rheumatoid arthritis	0.000165	0.000903	CcSEcCtD
Pimecrolimus—Vomiting—Leflunomide—rheumatoid arthritis	0.000163	0.000897	CcSEcCtD
Pimecrolimus—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000162	0.000891	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000162	0.00089	CcSEcCtD
Pimecrolimus—Epistaxis—Methotrexate—rheumatoid arthritis	0.000162	0.000889	CcSEcCtD
Pimecrolimus—Paraesthesia—Prednisolone—rheumatoid arthritis	0.000162	0.000889	CcSEcCtD
Pimecrolimus—Rash—Leflunomide—rheumatoid arthritis	0.000162	0.000889	CcSEcCtD
Pimecrolimus—Dermatitis—Leflunomide—rheumatoid arthritis	0.000162	0.000888	CcSEcCtD
Pimecrolimus—Nausea—Azathioprine—rheumatoid arthritis	0.000162	0.000887	CcSEcCtD
Pimecrolimus—Headache—Leflunomide—rheumatoid arthritis	0.000161	0.000883	CcSEcCtD
Pimecrolimus—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000161	0.000883	CcSEcCtD
Pimecrolimus—Malnutrition—Prednisone—rheumatoid arthritis	0.000161	0.000882	CcSEcCtD
Pimecrolimus—Erythema—Prednisone—rheumatoid arthritis	0.000161	0.000882	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.000161	0.000881	CcSEcCtD
Pimecrolimus—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000158	0.000869	CcSEcCtD
Pimecrolimus—Urticaria—Cyclosporine—rheumatoid arthritis	0.000158	0.000865	CcSEcCtD
Pimecrolimus—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000157	0.00086	CcSEcCtD
Pimecrolimus—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.000157	0.00086	CcSEcCtD
Pimecrolimus—Pain—Prednisolone—rheumatoid arthritis	0.000154	0.000847	CcSEcCtD
Pimecrolimus—Pharyngitis—Methotrexate—rheumatoid arthritis	0.000153	0.00084	CcSEcCtD
Pimecrolimus—Nausea—Leflunomide—rheumatoid arthritis	0.000153	0.000838	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000152	0.000835	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000151	0.00083	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000151	0.000828	CcSEcCtD
Pimecrolimus—Pain—Hydrocortisone—rheumatoid arthritis	0.000151	0.000827	CcSEcCtD
Pimecrolimus—Oedema—Dexamethasone—rheumatoid arthritis	0.000151	0.000826	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000151	0.000826	CcSEcCtD
Pimecrolimus—Oedema—Betamethasone—rheumatoid arthritis	0.000151	0.000826	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000151	0.000826	CcSEcCtD
Pimecrolimus—Infection—Betamethasone—rheumatoid arthritis	0.00015	0.000821	CcSEcCtD
Pimecrolimus—Infection—Dexamethasone—rheumatoid arthritis	0.00015	0.000821	CcSEcCtD
Pimecrolimus—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000149	0.000818	CcSEcCtD
Pimecrolimus—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000149	0.000816	CcSEcCtD
Pimecrolimus—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000148	0.000812	CcSEcCtD
Pimecrolimus—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000148	0.00081	CcSEcCtD
Pimecrolimus—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000148	0.00081	CcSEcCtD
Pimecrolimus—Angioedema—Prednisone—rheumatoid arthritis	0.000147	0.000806	CcSEcCtD
Pimecrolimus—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000146	0.000802	CcSEcCtD
Pimecrolimus—Eye disorder—Methotrexate—rheumatoid arthritis	0.000144	0.000791	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000144	0.000791	CcSEcCtD
Pimecrolimus—Urticaria—Prednisolone—rheumatoid arthritis	0.000143	0.000787	CcSEcCtD
Pimecrolimus—Pain—Triamcinolone—rheumatoid arthritis	0.000142	0.000779	CcSEcCtD
Pimecrolimus—Pruritus—Cyclosporine—rheumatoid arthritis	0.00014	0.00077	CcSEcCtD
Pimecrolimus—Urticaria—Hydrocortisone—rheumatoid arthritis	0.00014	0.000768	CcSEcCtD
Pimecrolimus—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000139	0.000765	CcSEcCtD
Pimecrolimus—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000139	0.000765	CcSEcCtD
Pimecrolimus—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000139	0.000765	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000139	0.000763	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000137	0.000753	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000137	0.000753	CcSEcCtD
Pimecrolimus—Arthralgia—Prednisone—rheumatoid arthritis	0.000137	0.000751	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000136	0.000746	CcSEcCtD
Pimecrolimus—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000136	0.000745	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000135	0.000743	CcSEcCtD
Pimecrolimus—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000135	0.000742	CcSEcCtD
Pimecrolimus—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000135	0.000742	CcSEcCtD
Pimecrolimus—Erythema—Methotrexate—rheumatoid arthritis	0.000134	0.000737	CcSEcCtD
Pimecrolimus—Malnutrition—Methotrexate—rheumatoid arthritis	0.000134	0.000737	CcSEcCtD
Pimecrolimus—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000133	0.00073	CcSEcCtD
Pimecrolimus—Urticaria—Triamcinolone—rheumatoid arthritis	0.000132	0.000724	CcSEcCtD
Pimecrolimus—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000132	0.000722	CcSEcCtD
Pimecrolimus—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000131	0.00072	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000131	0.00072	CcSEcCtD
Pimecrolimus—Oedema—Prednisone—rheumatoid arthritis	0.000131	0.00072	CcSEcCtD
Pimecrolimus—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000131	0.000718	CcSEcCtD
Pimecrolimus—Infection—Prednisone—rheumatoid arthritis	0.00013	0.000715	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.00013	0.000713	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.00013	0.000713	CcSEcCtD
Pimecrolimus—Back pain—Methotrexate—rheumatoid arthritis	0.00013	0.000713	CcSEcCtD
Pimecrolimus—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.00013	0.000713	CcSEcCtD
Pimecrolimus—Pain—Dexamethasone—rheumatoid arthritis	0.000129	0.000707	CcSEcCtD
Pimecrolimus—Pain—Betamethasone—rheumatoid arthritis	0.000129	0.000707	CcSEcCtD
Pimecrolimus—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000129	0.000706	CcSEcCtD
Pimecrolimus—Skin disorder—Prednisone—rheumatoid arthritis	0.000127	0.000699	CcSEcCtD
Pimecrolimus—Vomiting—Cyclosporine—rheumatoid arthritis	0.000126	0.000692	CcSEcCtD
Pimecrolimus—Rash—Cyclosporine—rheumatoid arthritis	0.000125	0.000686	CcSEcCtD
Pimecrolimus—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000125	0.000686	CcSEcCtD
Pimecrolimus—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000125	0.000684	CcSEcCtD
Pimecrolimus—Headache—Cyclosporine—rheumatoid arthritis	0.000124	0.000682	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000123	0.000676	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000123	0.000676	CcSEcCtD
Pimecrolimus—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000122	0.000671	CcSEcCtD
Pimecrolimus—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000122	0.00067	CcSEcCtD
Pimecrolimus—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000121	0.000662	CcSEcCtD
Pimecrolimus—Urticaria—Dexamethasone—rheumatoid arthritis	0.00012	0.000656	CcSEcCtD
Pimecrolimus—Urticaria—Betamethasone—rheumatoid arthritis	0.00012	0.000656	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000119	0.000656	CcSEcCtD
Pimecrolimus—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000119	0.000653	CcSEcCtD
Pimecrolimus—Body temperature increased—Betamethasone—rheumatoid arthritis	0.000119	0.000653	CcSEcCtD
Pimecrolimus—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000119	0.000653	CcSEcCtD
Pimecrolimus—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.000119	0.000653	CcSEcCtD
Pimecrolimus—Nausea—Cyclosporine—rheumatoid arthritis	0.000118	0.000646	CcSEcCtD
Pimecrolimus—Paraesthesia—Prednisone—rheumatoid arthritis	0.000118	0.000646	CcSEcCtD
Pimecrolimus—Pruritus—Triamcinolone—rheumatoid arthritis	0.000117	0.000644	CcSEcCtD
Pimecrolimus—Cough—Methotrexate—rheumatoid arthritis	0.000117	0.000643	CcSEcCtD
Pimecrolimus—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000117	0.000643	CcSEcCtD
Pimecrolimus—Arthralgia—Methotrexate—rheumatoid arthritis	0.000114	0.000627	CcSEcCtD
Pimecrolimus—Rash—Prednisolone—rheumatoid arthritis	0.000114	0.000624	CcSEcCtD
Pimecrolimus—Dermatitis—Prednisolone—rheumatoid arthritis	0.000114	0.000624	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000114	0.000623	CcSEcCtD
Pimecrolimus—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000113	0.000622	CcSEcCtD
Pimecrolimus—Headache—Prednisolone—rheumatoid arthritis	0.000113	0.00062	CcSEcCtD
Pimecrolimus—Constipation—Prednisone—rheumatoid arthritis	0.000112	0.000615	CcSEcCtD
Pimecrolimus—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000112	0.000615	CcSEcCtD
Pimecrolimus—Rash—Hydrocortisone—rheumatoid arthritis	0.000111	0.00061	CcSEcCtD
Pimecrolimus—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000111	0.000609	CcSEcCtD
Pimecrolimus—Headache—Hydrocortisone—rheumatoid arthritis	0.00011	0.000606	CcSEcCtD
Pimecrolimus—Anaphylactic shock—Methotrexate—rheumatoid arthritis	0.00011	0.000601	CcSEcCtD
Pimecrolimus—Infection—Methotrexate—rheumatoid arthritis	0.000109	0.000598	CcSEcCtD
Pimecrolimus—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000107	0.00059	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000107	0.000588	CcSEcCtD
Pimecrolimus—Nausea—Prednisolone—rheumatoid arthritis	0.000107	0.000588	CcSEcCtD
Pimecrolimus—Pruritus—Dexamethasone—rheumatoid arthritis	0.000107	0.000585	CcSEcCtD
Pimecrolimus—Pruritus—Betamethasone—rheumatoid arthritis	0.000107	0.000585	CcSEcCtD
Pimecrolimus—Skin disorder—Methotrexate—rheumatoid arthritis	0.000106	0.000584	CcSEcCtD
Pimecrolimus—Vomiting—Triamcinolone—rheumatoid arthritis	0.000106	0.000579	CcSEcCtD
Pimecrolimus—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000105	0.000578	CcSEcCtD
Pimecrolimus—Nausea—Hydrocortisone—rheumatoid arthritis	0.000105	0.000575	CcSEcCtD
Pimecrolimus—Rash—Triamcinolone—rheumatoid arthritis	0.000105	0.000574	CcSEcCtD
Pimecrolimus—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000105	0.000574	CcSEcCtD
Pimecrolimus—Rash—Methylprednisolone—rheumatoid arthritis	0.000104	0.000573	CcSEcCtD
Pimecrolimus—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000104	0.000572	CcSEcCtD
Pimecrolimus—Urticaria—Prednisone—rheumatoid arthritis	0.000104	0.000572	CcSEcCtD
Pimecrolimus—Headache—Triamcinolone—rheumatoid arthritis	0.000104	0.000571	CcSEcCtD
Pimecrolimus—Headache—Methylprednisolone—rheumatoid arthritis	0.000104	0.000569	CcSEcCtD
Pimecrolimus—Body temperature increased—Prednisone—rheumatoid arthritis	0.000104	0.000569	CcSEcCtD
Pimecrolimus—Abdominal pain—Prednisone—rheumatoid arthritis	0.000104	0.000569	CcSEcCtD
Pimecrolimus—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000103	0.000565	CcSEcCtD
Pimecrolimus—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000103	0.000565	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	9.99e-05	0.000548	CcSEcCtD
Pimecrolimus—Nausea—Triamcinolone—rheumatoid arthritis	9.86e-05	0.000541	CcSEcCtD
Pimecrolimus—Paraesthesia—Methotrexate—rheumatoid arthritis	9.84e-05	0.00054	CcSEcCtD
Pimecrolimus—Nausea—Methylprednisolone—rheumatoid arthritis	9.84e-05	0.00054	CcSEcCtD
Pimecrolimus—Dyspnoea—Methotrexate—rheumatoid arthritis	9.77e-05	0.000536	CcSEcCtD
Pimecrolimus—Hypersensitivity—Prednisone—rheumatoid arthritis	9.66e-05	0.00053	CcSEcCtD
Pimecrolimus—Vomiting—Dexamethasone—rheumatoid arthritis	9.58e-05	0.000525	CcSEcCtD
Pimecrolimus—Vomiting—Betamethasone—rheumatoid arthritis	9.58e-05	0.000525	CcSEcCtD
Pimecrolimus—Rash—Dexamethasone—rheumatoid arthritis	9.5e-05	0.000521	CcSEcCtD
Pimecrolimus—Rash—Betamethasone—rheumatoid arthritis	9.5e-05	0.000521	CcSEcCtD
Pimecrolimus—Dermatitis—Betamethasone—rheumatoid arthritis	9.49e-05	0.000521	CcSEcCtD
Pimecrolimus—Dermatitis—Dexamethasone—rheumatoid arthritis	9.49e-05	0.000521	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	9.46e-05	0.000519	CcSEcCtD
Pimecrolimus—Headache—Dexamethasone—rheumatoid arthritis	9.44e-05	0.000518	CcSEcCtD
Pimecrolimus—Headache—Betamethasone—rheumatoid arthritis	9.44e-05	0.000518	CcSEcCtD
Pimecrolimus—Pain—Methotrexate—rheumatoid arthritis	9.37e-05	0.000514	CcSEcCtD
Pimecrolimus—Pruritus—Prednisone—rheumatoid arthritis	9.28e-05	0.000509	CcSEcCtD
Pimecrolimus—Diarrhoea—Prednisone—rheumatoid arthritis	8.97e-05	0.000492	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	8.96e-05	0.000492	CcSEcCtD
Pimecrolimus—Nausea—Betamethasone—rheumatoid arthritis	8.95e-05	0.000491	CcSEcCtD
Pimecrolimus—Nausea—Dexamethasone—rheumatoid arthritis	8.95e-05	0.000491	CcSEcCtD
Pimecrolimus—Urticaria—Methotrexate—rheumatoid arthritis	8.71e-05	0.000478	CcSEcCtD
Pimecrolimus—Abdominal pain—Methotrexate—rheumatoid arthritis	8.67e-05	0.000475	CcSEcCtD
Pimecrolimus—Body temperature increased—Methotrexate—rheumatoid arthritis	8.67e-05	0.000475	CcSEcCtD
Pimecrolimus—Vomiting—Prednisone—rheumatoid arthritis	8.34e-05	0.000458	CcSEcCtD
Pimecrolimus—Rash—Prednisone—rheumatoid arthritis	8.27e-05	0.000454	CcSEcCtD
Pimecrolimus—Dermatitis—Prednisone—rheumatoid arthritis	8.26e-05	0.000453	CcSEcCtD
Pimecrolimus—Headache—Prednisone—rheumatoid arthritis	8.22e-05	0.000451	CcSEcCtD
Pimecrolimus—Hypersensitivity—Methotrexate—rheumatoid arthritis	8.08e-05	0.000443	CcSEcCtD
Pimecrolimus—Nausea—Prednisone—rheumatoid arthritis	7.79e-05	0.000427	CcSEcCtD
Pimecrolimus—Pruritus—Methotrexate—rheumatoid arthritis	7.76e-05	0.000426	CcSEcCtD
Pimecrolimus—Diarrhoea—Methotrexate—rheumatoid arthritis	7.5e-05	0.000412	CcSEcCtD
Pimecrolimus—Vomiting—Methotrexate—rheumatoid arthritis	6.97e-05	0.000382	CcSEcCtD
Pimecrolimus—Rash—Methotrexate—rheumatoid arthritis	6.91e-05	0.000379	CcSEcCtD
Pimecrolimus—Dermatitis—Methotrexate—rheumatoid arthritis	6.91e-05	0.000379	CcSEcCtD
Pimecrolimus—Headache—Methotrexate—rheumatoid arthritis	6.87e-05	0.000377	CcSEcCtD
Pimecrolimus—Nausea—Methotrexate—rheumatoid arthritis	6.51e-05	0.000357	CcSEcCtD
Pimecrolimus—MTOR—Signaling Pathways—PLB1—rheumatoid arthritis	5.44e-05	0.00034	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NCF1—rheumatoid arthritis	5.39e-05	0.000336	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IRF8—rheumatoid arthritis	5.35e-05	0.000334	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CCR6—rheumatoid arthritis	5.35e-05	0.000334	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—ITGAM—rheumatoid arthritis	5.35e-05	0.000334	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—TP53—rheumatoid arthritis	5.31e-05	0.000331	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—AGER—rheumatoid arthritis	5.22e-05	0.000326	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—SLC11A1—rheumatoid arthritis	5.21e-05	0.000325	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—NCF2—rheumatoid arthritis	5.2e-05	0.000325	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD40LG—rheumatoid arthritis	5.2e-05	0.000324	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CD28—rheumatoid arthritis	5.18e-05	0.000323	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NFATC1—rheumatoid arthritis	5.17e-05	0.000322	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—HLA-B—rheumatoid arthritis	5.15e-05	0.000321	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD8A—rheumatoid arthritis	5.14e-05	0.000321	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—IL6—rheumatoid arthritis	5.13e-05	0.00032	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—FCGR2A—rheumatoid arthritis	5.1e-05	0.000318	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—TRAF6—rheumatoid arthritis	5.07e-05	0.000316	CbGpPWpGaD
Pimecrolimus—CYP3A4—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	5.03e-05	0.000314	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RBPJ—rheumatoid arthritis	5.02e-05	0.000313	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—TNFAIP3—rheumatoid arthritis	5.01e-05	0.000312	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—NFKB1—rheumatoid arthritis	4.95e-05	0.000309	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—BLK—rheumatoid arthritis	4.95e-05	0.000309	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-B—rheumatoid arthritis	4.94e-05	0.000308	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—IL6—rheumatoid arthritis	4.91e-05	0.000306	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PTPN2—rheumatoid arthritis	4.89e-05	0.000305	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—UBE2D1—rheumatoid arthritis	4.88e-05	0.000304	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—MAPK8—rheumatoid arthritis	4.87e-05	0.000304	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—IL6—rheumatoid arthritis	4.83e-05	0.000301	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NCF2—rheumatoid arthritis	4.8e-05	0.0003	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—SAA1—rheumatoid arthritis	4.78e-05	0.000298	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—C3—rheumatoid arthritis	4.78e-05	0.000298	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—BDKRB2—rheumatoid arthritis	4.78e-05	0.000298	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCL12—rheumatoid arthritis	4.78e-05	0.000298	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ADRBK1—rheumatoid arthritis	4.73e-05	0.000295	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CTSD—rheumatoid arthritis	4.68e-05	0.000292	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—NCF1—rheumatoid arthritis	4.68e-05	0.000292	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CCR5—rheumatoid arthritis	4.68e-05	0.000292	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—NFKB1—rheumatoid arthritis	4.64e-05	0.00029	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—IL6—rheumatoid arthritis	4.61e-05	0.000288	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—C3—rheumatoid arthritis	4.59e-05	0.000287	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—IL6—rheumatoid arthritis	4.59e-05	0.000286	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-A—rheumatoid arthritis	4.58e-05	0.000286	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—MTHFR—rheumatoid arthritis	4.57e-05	0.000285	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—IL6—rheumatoid arthritis	4.57e-05	0.000285	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—MAPK8—rheumatoid arthritis	4.56e-05	0.000285	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—HLA-A—rheumatoid arthritis	4.56e-05	0.000284	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CRP—rheumatoid arthritis	4.55e-05	0.000284	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—IL6—rheumatoid arthritis	4.55e-05	0.000284	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD28—rheumatoid arthritis	4.5e-05	0.000281	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—VEGFA—rheumatoid arthritis	4.49e-05	0.00028	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—RASGRP1—rheumatoid arthritis	4.46e-05	0.000278	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SYK—rheumatoid arthritis	4.45e-05	0.000277	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL13—rheumatoid arthritis	4.44e-05	0.000277	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PTPRC—rheumatoid arthritis	4.42e-05	0.000276	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—SAA1—rheumatoid arthritis	4.42e-05	0.000276	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL1RN—rheumatoid arthritis	4.4e-05	0.000275	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PRKCQ—rheumatoid arthritis	4.36e-05	0.000272	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—TLR4—rheumatoid arthritis	4.36e-05	0.000272	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NCF1—rheumatoid arthritis	4.32e-05	0.00027	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—STAT1—rheumatoid arthritis	4.29e-05	0.000267	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—ENO1—rheumatoid arthritis	4.28e-05	0.000267	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—IL6—rheumatoid arthritis	4.28e-05	0.000267	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—IL6—rheumatoid arthritis	4.28e-05	0.000267	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—rheumatoid arthritis	4.28e-05	0.000267	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-DPB1—rheumatoid arthritis	4.28e-05	0.000267	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—UBE2D1—rheumatoid arthritis	4.24e-05	0.000265	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—IL6—rheumatoid arthritis	4.24e-05	0.000264	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCL10—rheumatoid arthritis	4.23e-05	0.000264	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—IL6—rheumatoid arthritis	4.2e-05	0.000262	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—HLA-DRB1—rheumatoid arthritis	4.18e-05	0.000261	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—IL6—rheumatoid arthritis	4.18e-05	0.000261	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—IL6ST—rheumatoid arthritis	4.18e-05	0.000261	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CD28—rheumatoid arthritis	4.16e-05	0.000259	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD40—rheumatoid arthritis	4.11e-05	0.000257	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—ADRBK1—rheumatoid arthritis	4.11e-05	0.000257	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CTLA4—rheumatoid arthritis	4.05e-05	0.000253	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HMGB1—rheumatoid arthritis	4.05e-05	0.000253	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CD80—rheumatoid arthritis	4.03e-05	0.000251	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—ICAM1—rheumatoid arthritis	4.02e-05	0.000251	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IL6ST—rheumatoid arthritis	4e-05	0.000249	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IRAK1—rheumatoid arthritis	4e-05	0.000249	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TLE3—rheumatoid arthritis	4e-05	0.000249	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NOS2—rheumatoid arthritis	3.97e-05	0.000247	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CX3CR1—rheumatoid arthritis	3.96e-05	0.000247	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—UBE2D1—rheumatoid arthritis	3.92e-05	0.000244	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—RASGRP1—rheumatoid arthritis	3.88e-05	0.000242	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—SYK—rheumatoid arthritis	3.87e-05	0.000241	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD79A—rheumatoid arthritis	3.87e-05	0.000241	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD80—rheumatoid arthritis	3.87e-05	0.000241	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MMP3—rheumatoid arthritis	3.85e-05	0.00024	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CD80—rheumatoid arthritis	3.85e-05	0.00024	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL2RB—rheumatoid arthritis	3.81e-05	0.000238	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—ADRBK1—rheumatoid arthritis	3.8e-05	0.000237	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PRKCQ—rheumatoid arthritis	3.8e-05	0.000237	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—rheumatoid arthritis	3.79e-05	0.000236	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—IL6R—rheumatoid arthritis	3.73e-05	0.000233	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—STAT1—rheumatoid arthritis	3.73e-05	0.000233	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PTK2—rheumatoid arthritis	3.71e-05	0.000231	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—C5—rheumatoid arthritis	3.68e-05	0.000229	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CCL5—rheumatoid arthritis	3.64e-05	0.000227	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NFATC1—rheumatoid arthritis	3.62e-05	0.000226	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CSF2—rheumatoid arthritis	3.58e-05	0.000224	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—VCAM1—rheumatoid arthritis	3.58e-05	0.000223	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-DQA1—rheumatoid arthritis	3.57e-05	0.000223	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IL6R—rheumatoid arthritis	3.57e-05	0.000223	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PRKCQ—rheumatoid arthritis	3.5e-05	0.000219	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCR6—rheumatoid arthritis	3.46e-05	0.000216	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—STAT1—rheumatoid arthritis	3.44e-05	0.000215	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—TYK2—rheumatoid arthritis	3.4e-05	0.000212	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—TP53—rheumatoid arthritis	3.39e-05	0.000212	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SPP1—rheumatoid arthritis	3.37e-05	0.00021	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NCF2—rheumatoid arthritis	3.36e-05	0.00021	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-DQB1—rheumatoid arthritis	3.34e-05	0.000208	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SH2B3—rheumatoid arthritis	3.28e-05	0.000204	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TRAF6—rheumatoid arthritis	3.28e-05	0.000204	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CCR5—rheumatoid arthritis	3.28e-05	0.000204	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GZMB—rheumatoid arthritis	3.26e-05	0.000203	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—TYK2—rheumatoid arthritis	3.25e-05	0.000203	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL2RA—rheumatoid arthritis	3.23e-05	0.000201	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PTK2—rheumatoid arthritis	3.23e-05	0.000201	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—C3—rheumatoid arthritis	3.2e-05	0.0002	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NOS3—rheumatoid arthritis	3.19e-05	0.000199	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL1A—rheumatoid arthritis	3.17e-05	0.000198	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL18—rheumatoid arthritis	3.16e-05	0.000197	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL2—rheumatoid arthritis	3.16e-05	0.000197	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL3—rheumatoid arthritis	3.16e-05	0.000197	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	3.15e-05	0.000197	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD40LG—rheumatoid arthritis	3.15e-05	0.000197	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CSF2—rheumatoid arthritis	3.12e-05	0.000194	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD8A—rheumatoid arthritis	3.12e-05	0.000194	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—IL6—rheumatoid arthritis	3.11e-05	0.000194	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SAA1—rheumatoid arthritis	3.09e-05	0.000193	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CD4—rheumatoid arthritis	3.07e-05	0.000192	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—AGER—rheumatoid arthritis	3.04e-05	0.00019	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NCF1—rheumatoid arthritis	3.03e-05	0.000189	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-B—rheumatoid arthritis	3e-05	0.000187	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—LEP—rheumatoid arthritis	2.98e-05	0.000186	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD4—rheumatoid arthritis	2.95e-05	0.000184	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CD4—rheumatoid arthritis	2.94e-05	0.000183	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—PTGS2—rheumatoid arthritis	2.92e-05	0.000182	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—IL6—rheumatoid arthritis	2.91e-05	0.000182	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CD28—rheumatoid arthritis	2.91e-05	0.000182	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—FN1—rheumatoid arthritis	2.81e-05	0.000175	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL2RA—rheumatoid arthritis	2.81e-05	0.000175	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL6ST—rheumatoid arthritis	2.8e-05	0.000175	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—C3—rheumatoid arthritis	2.79e-05	0.000174	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-A—rheumatoid arthritis	2.78e-05	0.000173	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—UBE2D1—rheumatoid arthritis	2.74e-05	0.000171	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CD80—rheumatoid arthritis	2.7e-05	0.000168	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—BDKRB2—rheumatoid arthritis	2.69e-05	0.000168	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL12—rheumatoid arthritis	2.69e-05	0.000168	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	2.67e-05	0.000167	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ADRBK1—rheumatoid arthritis	2.66e-05	0.000166	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CRP—rheumatoid arthritis	2.65e-05	0.000165	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—NFKB1—rheumatoid arthritis	2.65e-05	0.000165	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CCR5—rheumatoid arthritis	2.63e-05	0.000164	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—MAPK8—rheumatoid arthritis	2.6e-05	0.000162	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—MTHFR—rheumatoid arthritis	2.57e-05	0.00016	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—HLA-A—rheumatoid arthritis	2.56e-05	0.00016	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—POMC—rheumatoid arthritis	2.56e-05	0.00016	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—NFKB1—rheumatoid arthritis	2.54e-05	0.000159	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—TLR4—rheumatoid arthritis	2.54e-05	0.000158	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—HLA-DRB1—rheumatoid arthritis	2.54e-05	0.000158	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RASGRP1—rheumatoid arthritis	2.51e-05	0.000156	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CCL2—rheumatoid arthritis	2.51e-05	0.000156	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SYK—rheumatoid arthritis	2.5e-05	0.000156	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL6R—rheumatoid arthritis	2.5e-05	0.000156	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PRKCQ—rheumatoid arthritis	2.45e-05	0.000153	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL6ST—rheumatoid arthritis	2.44e-05	0.000152	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—ICAM1—rheumatoid arthritis	2.44e-05	0.000152	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—STAT1—rheumatoid arthritis	2.41e-05	0.00015	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL10—rheumatoid arthritis	2.38e-05	0.000148	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD80—rheumatoid arthritis	2.34e-05	0.000146	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TYK2—rheumatoid arthritis	2.28e-05	0.000142	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IL6ST—rheumatoid arthritis	2.25e-05	0.00014	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NOS3—rheumatoid arthritis	2.23e-05	0.000139	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOS2—rheumatoid arthritis	2.23e-05	0.000139	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL6R—rheumatoid arthritis	2.17e-05	0.000136	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MMP3—rheumatoid arthritis	2.17e-05	0.000135	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CD80—rheumatoid arthritis	2.16e-05	0.000135	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—TGFB1—rheumatoid arthritis	2.11e-05	0.000132	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	2.1e-05	0.000131	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PTK2—rheumatoid arthritis	2.09e-05	0.00013	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL5—rheumatoid arthritis	2.05e-05	0.000128	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	2.03e-05	0.000127	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CSF2—rheumatoid arthritis	2.02e-05	0.000126	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IL6R—rheumatoid arthritis	2.01e-05	0.000125	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.98e-05	0.000124	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—TYK2—rheumatoid arthritis	1.98e-05	0.000123	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	1.91e-05	0.000119	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SPP1—rheumatoid arthritis	1.89e-05	0.000118	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL2—rheumatoid arthritis	1.89e-05	0.000118	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GC—rheumatoid arthritis	1.86e-05	0.000116	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	1.86e-05	0.000116	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IFNG—rheumatoid arthritis	1.85e-05	0.000116	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCR5—rheumatoid arthritis	1.84e-05	0.000115	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—TYK2—rheumatoid arthritis	1.83e-05	0.000114	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL2RA—rheumatoid arthritis	1.82e-05	0.000113	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—C3—rheumatoid arthritis	1.8e-05	0.000112	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOS3—rheumatoid arthritis	1.79e-05	0.000112	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MMP9—rheumatoid arthritis	1.79e-05	0.000112	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD4—rheumatoid arthritis	1.79e-05	0.000112	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NFKB1—rheumatoid arthritis	1.77e-05	0.000111	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MAPK8—rheumatoid arthritis	1.74e-05	0.000109	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	1.73e-05	0.000108	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—LEP—rheumatoid arthritis	1.68e-05	0.000105	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—IL6—rheumatoid arthritis	1.66e-05	0.000104	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL1B—rheumatoid arthritis	1.65e-05	0.000103	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CD4—rheumatoid arthritis	1.65e-05	0.000103	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL2—rheumatoid arthritis	1.65e-05	0.000103	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PTGS2—rheumatoid arthritis	1.64e-05	0.000102	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—VEGFA—rheumatoid arthritis	1.61e-05	0.0001	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IL6—rheumatoid arthritis	1.59e-05	9.91e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—FN1—rheumatoid arthritis	1.58e-05	9.86e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL6ST—rheumatoid arthritis	1.57e-05	9.82e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—NFKB1—rheumatoid arthritis	1.54e-05	9.62e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—MAPK8—rheumatoid arthritis	1.52e-05	9.46e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CD80—rheumatoid arthritis	1.52e-05	9.46e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—MED1—rheumatoid arthritis	1.51e-05	9.45e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TGFB1—rheumatoid arthritis	1.48e-05	9.21e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—POMC—rheumatoid arthritis	1.44e-05	8.99e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL2—rheumatoid arthritis	1.41e-05	8.79e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	1.41e-05	8.78e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	1.41e-05	8.78e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL6R—rheumatoid arthritis	1.41e-05	8.77e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TYK2—rheumatoid arthritis	1.28e-05	7.98e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—BGN—rheumatoid arthritis	1.27e-05	7.91e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NOS3—rheumatoid arthritis	1.26e-05	7.84e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TP53—rheumatoid arthritis	1.22e-05	7.58e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—TGFB1—rheumatoid arthritis	1.19e-05	7.4e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	1.17e-05	7.28e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL8—rheumatoid arthritis	1.11e-05	6.95e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL6—rheumatoid arthritis	1.11e-05	6.94e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL2—rheumatoid arthritis	1.06e-05	6.64e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MMP9—rheumatoid arthritis	1.01e-05	6.29e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NFKB1—rheumatoid arthritis	9.97e-06	6.22e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MAPK8—rheumatoid arthritis	9.8e-06	6.11e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL6—rheumatoid arthritis	9.68e-06	6.04e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	9.51e-06	5.93e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—VEGFA—rheumatoid arthritis	9.05e-06	5.65e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IL6—rheumatoid arthritis	8.94e-06	5.58e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TGFB1—rheumatoid arthritis	8.31e-06	5.18e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CAT—rheumatoid arthritis	6.85e-06	4.27e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TP53—rheumatoid arthritis	6.84e-06	4.27e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL6—rheumatoid arthritis	6.26e-06	3.9e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	5.71e-06	3.56e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—POMC—rheumatoid arthritis	4.57e-06	2.85e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALB—rheumatoid arthritis	4.17e-06	2.6e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	3.98e-06	2.49e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	3.64e-06	2.27e-05	CbGpPWpGaD
